“Treatment Related Adverse Events and Monitoring of Patients Receiving Biologic or Small Molecule Therapy for Inflammatory Bowel Disease”, Can IBD Today, vol. 2, no. 2, pp. 19–27, Sep. 2024, doi: 10.58931/cibdt.2024.2230.